TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

NCT06589830 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer Metastatic
Advanced Colorectal Cancer

Interventions

DRUG: TL938 Capsules
DRUG: Trastuzumab

Sponsor

Suzhou Teligene Ltd.